Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 1/20 | 0.32 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.32 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13397769 | 0.73 | OPRD1 (0.36) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL19402457 | 0.71 | — | — | |
| SCHEMBL9628547 | 0.71 | — | — | |
| SCHEMBL19402456 | 0.71 | — | — | |
| SCHEMBL1408895 | 0.71 | — | — | |
| SCHEMBL2102574 | 0.71 | — | — | |
| SCHEMBL2101769 | 0.69 | — | — | |
| SCHEMBL15998595 | 0.69 | — | — | |
| SCHEMBL19605793 | 0.69 | — | — | |
| SCHEMBL1979234 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115156-B2 | Biodegradable phosphoester polyamines | COVIDIEN LP (US) | 2015-08-25 | — | — | US | claimed |
| US-20140051879-A1 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | COVIDIEN LP (US) | 2014-02-20 | — | — | US | claimed |
| EP-1991161-B1 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | TYCO HEALTHCARE (US) | 2012-11-07 | — | — | EP | claimed |
| EP-1991161-A2 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | Tyco Healthcare Group, LP (US) | 2008-11-19 | — | — | EP | claimed |
| US-20080279807-A1 | Biodegradable Phosphoester Polyamines | COVIDIEN LP | 2008-11-13 | — | — | US | claimed |
| WO-2007100574-A2 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | TYCO HEALTHCARE GROUP LP (US) | 2007-09-07 | — | — | WO | claimed |
| EP-0306861-B1 | STABILISATION OF CHLOROFLUOROALKANES | Kali-Chemie Aktiengesellschaft (DE) | 1992-12-30 | — | — | EP | claimed |
| EP-0306861-A2 | Stabilisation of chlorofluoroalkanes | Kali-Chemie Aktiengesellschaft (DE) | 1989-03-15 | — | — | EP | claimed |
| EP-3974459-B1 | HYDROGENATED COPOLYMER COMPOSITION, ADHESIVE FILM, RESIN COMPOSITION, AND MOLDED ARTICLE | ASAHI CHEMICAL IND (JP) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023238519-A1 | LAMINATE AND METHOD FOR MANUFACTURING LAMINATE | 旭化成株式会社 | 2023-12-14 | — | — | WO | disclosed |
| WO-2023223766-A1 | THERMOPLASTIC ELASTOMER COMPOSITION FOR MULTILAYER MOLDING, MULTILAYER MOLDED BODY, AND MULTILAYER MOLDED BODY MANUFACTURING METHOD | 旭化成株式会社 | 2023-11-23 | — | — | WO | disclosed |
| WO-2023224063-A1 | HYDROGENATED CONJUGATED DIENE COPOLYMER, RESIN COMPOSITION, CURED PRODUCT, RESIN FILM, PREPREG, LAMINATE, AND PRINTED WIRING BOARD | 旭化成株式会社 | 2023-11-23 | — | — | WO | disclosed |
| EP-3766905-B1 | HYDROGENATED BLOCK COPOLYMER, HYDROGENATED BLOCK COPOLYMER COMPOSITION, AND MOLDED ARTICLE | ASAHI CHEMICAL IND (JP) | 2023-11-08 | — | — | EP | disclosed |
| US-20230303752-A1 | Hydrogenated Copolymer, Resin Composition, Molded Article, and Adhesive Film | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-09-28 | — | — | US | disclosed |
| EP-0306861-B1 | STABILISATION OF CHLOROFLUOROALKANES | Kali-Chemie Aktiengesellschaft (DE) | 1992-12-30 | — | — | EP | disclosed |
| EP-0503441-A1 | Stabilization of dichlorotrifluoroethane | Solvay Fluor und Derivate GmbH (DE) | 1992-09-16 | — | — | EP | disclosed |
| EP-0306861-A2 | Stabilisation of chlorofluoroalkanes | Kali-Chemie Aktiengesellschaft (DE) | 1989-03-15 | — | — | EP | disclosed |
| EP-0086278-B1 | PROCESS FOR THE PRODUCTION OF HYDANTOIN ESTERS | BAYER AG (DE) | 1986-02-26 | — | — | EP | disclosed |
| EP-0086278-A1 | Process for the production of hydantoin esters | BAYER AG (DE) | 1983-08-24 | — | — | EP | disclosed |
| EP-0076471-A2 | Stabilisation of polyether or polyester moulding compounds against premature reaction | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080279807-A1 | Biodegradable Phosphoester Polyamines | PHOSPHO1, SRM, SGMS1 | PRMT3 76/4885CARM1 684/4885PRMT6 51/4885 |
| US-20140051879-A1 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | PHOSPHO1, SRM, SGMS1 | PRMT3 76/4885CARM1 684/4885PRMT6 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.